APA aipamena

Balendra, R., Moens, T. G., & Isaacs, A. M. (2017). Specific biomarkers for C9orf72 FTD/ALS could expedite the journey towards effective therapies. EMBO Mol Med.

Chicago Style aipamena

Balendra, Rubika, Thomas G. Moens, and Adrian M. Isaacs. "Specific Biomarkers for C9orf72 FTD/ALS Could Expedite the Journey Towards Effective Therapies." EMBO Mol Med 2017.

MLA aipamena

Balendra, Rubika, Thomas G. Moens, and Adrian M. Isaacs. "Specific Biomarkers for C9orf72 FTD/ALS Could Expedite the Journey Towards Effective Therapies." EMBO Mol Med 2017.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.